Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CenraTPE:3716 -0.46%15 FCF Margin % is 9.46% as of Dec. 2025, which is 95% above its 10-year median of 4.84. GuruFocus rates TPE:3716 with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 117 Medical Distribution companies, Cenra ranks better than 81.2% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cenra's Free Cash Flow for the
three
months ended in Dec. 2025 was NT$203 Mil. Cenra's Revenue for the
three
months ended in Dec. 2025 was NT$2,146 Mil. Therefore, Cenra's FCF Margin % for the quarter that ended in Dec. 2025 was 9.46%.
The historical data trend for Cenra's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:3716 vs MCK, COR, CAH: FCF Margin % Comparison
For the Medical Distribution subindustry, Cenra's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cenra FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cenra's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Cenra's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cenra (TPE:3716) has a FCF Margin % of 9.46% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cenra and its competitors. This is 95% above median its historical median of 4.84. According to the industry distribution chart, Cenra ranks #22 out of 117 companies in the Medical Distribution industry, placing it in the top 18.8%.
Is Cenra's FCF Margin % too high?
Cenra's current FCF Margin % of 9.46% is 95% above median its 10-year median of 4.84. The Medical Distribution industry median FCF Margin % is 0.96. Cenra's value of 9.46% is 885.4% above this industry median. Based on the distribution chart, Cenra ranks #22 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cenra has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Cenra's FCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Cenra ranks #22 out of 117 companies for FCF Margin %. This places Cenra in the top 19% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 0.96. Cenra's value of 9.46% is 885.4% above this benchmark. While the company's 10-year median is 4.84 vs. the industry median of 0.96, Cenra has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 0.96, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cenra's current FCF Margin % of 9.46% is 885.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cenra and its competitors. For the Medical Distribution industry, the median FCF Margin % is 0.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cenra's current FCF Margin % is 9.46%, which is 95% above median its own 10-year median of 4.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cenra stock overvalued right now?
Cenra (TPE:3716) has a current FCF Margin % of 9.46%. The current FCF Margin % is 9.46%, which is 95% above median its 10-year median of 4.84 and 885.4% above the Medical Distribution industry median of 0.96. Cenra's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cenra (TPE:3716), the current FCF Margin % is 9.46% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3716 has been successfully added to your 
